James L. Heppell - Sep 14, 2021 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ James L. Heppell
Stock symbol
SKYE
Transactions as of
Sep 14, 2021
Transactions value $
$0
Form type
4
Date filed
9/16/2021, 04:02 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Director Stock Option (Right to Buy) Award $0 +150K +12.5% $0.00 1.35M Sep 14, 2021 Common Stock 150K $0.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option shall be exercisable for a price of $0.12 per Option Share in twelve equal monthly installments such that all the Option Shares shall vest in twelve months.